Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study.

Maqutu D, Zewotir T, North D, Naidoo K, Grobler A.

AIDS Behav. 2011 Oct;15(7):1465-74. doi: 10.1007/s10461-010-9688-x.

2.

Optimal HAART adherence over time and time interval between successive visits: their association and determinants.

Maqutu D, Zewotir T.

AIDS Care. 2011 Nov;23(11):1417-24. doi: 10.1080/09540121.2011.565028. Epub 2011 Jul 18.

3.

Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa.

Focà E, Odolini S, Sulis G, Calza S, Pietra V, Rodari P, Giorgetti PF, Noris A, Ouedraogo P, Simpore J, Pignatelli S, Castelli F.

BMC Infect Dis. 2014 Mar 21;14:153. doi: 10.1186/1471-2334-14-153.

4.

Factors affecting first-month adherence to antiretroviral therapy among HIV-positive adults in South Africa.

Maqutu D, Zewotir T, North D, Naidoo K, Grobler A.

Afr J AIDS Res. 2010 Sep 22;9(2):117-124.

5.

Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.

Silveira MP, Maurer P, Guttier MC, Moreira LB.

J Clin Pharm Ther. 2015 Apr;40(2):192-5. doi: 10.1111/jcpt.12233. Epub 2014 Nov 25.

PMID:
25422132
6.

Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa.

Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J.

BMC Public Health. 2010 Mar 5;10:111. doi: 10.1186/1471-2458-10-111.

7.
8.

Self-reported adherence to antiretroviral therapy in HIV+ population from Bata, Equatorial Guinea.

Salmanton-García J, Herrador Z, Ruiz-Seco P, Nzang-Esono J, Bendomo V, Bashmakovic E, Nseng-Nchama G, Benito A, Aparicio P.

AIDS Care. 2016;28(5):543-53. doi: 10.1080/09540121.2015.1124976. Epub 2015 Dec 24.

PMID:
26698540
9.

Preparing for highly active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model.

Simon MD, Altice FL, Moll AP, Shange M, Friedland GH.

AIDS Care. 2010 Apr;22(4):462-74. doi: 10.1080/09540120903220253.

PMID:
20204909
10.

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):78-84.

PMID:
16878045
11.

Factors associated with mortality in HIV-infected people in rural and urban South Africa.

Otwombe KN, Petzold M, Modisenyane T, Martinson NA, Chirwa T.

Glob Health Action. 2014 Sep 29;7:25488. doi: 10.3402/gha.v7.25488. eCollection 2014.

12.

Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.

Nakimuli-Mpungu E, Mutamba B, Othengo M, Musisi S.

Afr Health Sci. 2009 Aug 1;9 Suppl 1:S2-7.

13.

The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa.

Kakinami L, de Bruyn G, Pronyk P, Mohapi L, Tshabangu N, Moshabela M, McIntyre J, Martinson NA.

AIDS Behav. 2011 May;15(4):823-31. doi: 10.1007/s10461-010-9776-y.

PMID:
20703794
14.

Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada.

O'Neil CR, Palmer AK, Coulter S, O'Brien N, Shen A, Zhang W, Montaner JS, Hogg RS.

J Int Assoc Physicians AIDS Care (Chic). 2012 Mar-Apr;11(2):134-41. doi: 10.1177/1545109711423976. Epub 2012 Feb 7.

PMID:
22318879
16.

Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.

Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.

Antivir Ther. 2004 Jun;9(3):407-14.

PMID:
15259903
17.

Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics.

Venkatesh KK, de Bruyn G, Lurie MN, Mohapi L, Pronyk P, Moshabela M, Marinda E, Gray GE, Triche EW, Martinson NA.

AIDS. 2010 Nov 13;24(17):2687-96. doi: 10.1097/QAD.0b013e32833e78d4.

18.

Factors influencing adherence to antiretroviral medication in Ilorin, Nigeria.

Alakija Kazeem Salami, Fadeyi A, Ogunmodede JA, Desalu O.

J Int Assoc Physicians AIDS Care (Chic). 2010 May-Jun;9(3):191-5. doi: 10.1177/1545109710368722.

PMID:
20530474
19.

The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.

Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, Niyang M, Biadgilign S.

J Int Assoc Provid AIDS Care. 2014 Jul-Aug;13(4):346-52.

PMID:
24114726
20.

Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.

Applebaum AJ, Richardson MA, Brady SM, Brief DJ, Keane TM.

AIDS Behav. 2009 Feb;13(1):60-5. doi: 10.1007/s10461-008-9441-x. Epub 2008 Aug 9.

PMID:
18690532

Supplemental Content

Support Center